Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

FlexToBa for People With Multiple Sclerosis

21 de febrero de 2017 actualizado por: Edward McAuley, University of Illinois at Urbana-Champaign

Improving Functional Performance in Persons With MS Via Physical Activity DVD Intervention

The purpose of this study is to test the effectiveness of a DVD-delivered, home-based six-month physical activity intervention for people with Multiple Sclerosis.

Descripción general del estudio

Descripción detallada

Persons with MS are less likely to be active than their healthy counterparts, a statistic that is compounded by the symptom manifestations of MS. However, there is increasing evidence to support the importance of physical activity in MS. Unfortunately, structured, safe, and efficacious physical activity programs that are often conducted in medical or university settings are often not accessible to many older adults with or without MS. We propose to conduct a randomized controlled pilot trial testing the efficacy of a DVD-delivered physical activity intervention which targets factors that have the potential to reduce disability in older adults with MS. This DVD-based intervention has been previously approved by the IRB at the University of Illinois for a similar study with low-active, community-dwelling older adults (IRB Protocol Number: 09765). This novel intervention provides systematic, programmatic activities with alternative versions of each exercise that allow individuals of all capabilities to complete the program successfully. It focuses on improving flexibility, strength, and balance and has been demonstrated to be feasible, well-accepted, and efficacious in a large sample of older adults without MS. Importantly, intervention resulted in clinically significant improvements in the Short Physical Performance Battery, reliable determinant of disability, institutionalization, morbidity, and mortality. If such an intervention was equally successful in older persons with MS, this could have considerable public health impact.

Tipo de estudio

Intervencionista

Inscripción (Actual)

50

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Illinois
      • Urbana, Illinois, Estados Unidos, 61801
        • University of Illinois at Urbana-Champaign

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

50 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • being non-active, defined as reporting not engaging in regular activity (30 minutes accumulated per day) on more than two days of the week in the prior six months;
  • aged 50 years and older;
  • fluent in English;
  • relapse-free in the last 30 days;
  • ambulatory with minimal assistance(i.e., walk independently or with a single-point assistive walking device such as a cane);
  • the provision of medical clearance for participation in a physical activity program by participants' physicians, along with a physician-confirmed diagnosis of MS (communication with physicians will be facilitated by research staff).

Exclusion Criteria:

  • self-reported physical activity on a regular basis within the last six months (2 times or more per week);
  • younger than 50 years of age;
  • relapse in the last 30 days;
  • no regular access to a television;
  • no physician-confirmed diagnosis of multiple sclerosis;
  • unable to successfully score above 21 (out of 39)on the Telephone Interview of Cognitive Status questionnaire (TICS-M).

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Experimental: FlexToBa physical activity DVD
Participants in this arm will receive a physical activity program delivered by DVD that focuses on exercises targeting flexibility, toning and balance. These exercises will be progressive in nature throughout the six months and will also focus on modifications for all ability levels. Participants will be provided with three DVDs including: an Introduction to physical activity, Sessions 1-3, and Sessions 4-6, which they will be asked to watch and participate in over the course of six months.
Subjects will be participating in a home-based physical activity program that focuses on flexibility, toning and balance. Exercises will be progressive over the six-months and will highlight modifications for varying levels. This program will be delivered on 3 DVDs. Participants will be asked to exercise with the DVD at least three times per week.
Comparador activo: Usual care-Wait list
Participants in this arm will receive a DVD that focuses on healthy aging topics but does not include physical activity. They will receive the FlexToBa DVD after the completion of the 6-month follow-up testing.
Participants in this arm will receive a DVD that focuses on healthy aging topics but does not include physical activity. They will receive the FlexToBa DVD after the completion of the 6-month follow-up testing.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change from baseline to six-months in assessments of functional fitness of sedentary adults who have Multiple Sclerosis
Periodo de tiempo: Baseline and six months

The measurements will include:

Short physical performance battery -- measures walking speed, ability to rise from a chair, and standing balance

Baseline and six months
Change from baseline to six-months in assessments of functional fitness of sedentary adults who have MS
Periodo de tiempo: Baseline and six-months

Measurements will include:

Timed 20-foot walk test -- walk 25 feet as quickly as possible;

Baseline and six-months
Change in assessments of functional fitness assessments in sedentary adults with MS
Periodo de tiempo: Baseline and six-months

Measurements will include:

6-minute walk test -- walk as much as possible (in terms of distance) for 6 minutes;

Baseline and six-months
Change from baseline to six-months in assessments of functional fitness of sedentary adults with MS
Periodo de tiempo: Baseline and six-months

Measurements will include:

Grip strength -- using a dynamometer, participants will demonstrate isometric grip strength;

Baseline and six-months
Change from baseline to six-months in assessments of functional fitness of sedentary adults who have MS
Periodo de tiempo: Baseline and six-months

Measurements will include:

Flexibility -- sit and reach (lower body flexibility) and back scratch test (upper body flexibility)

Baseline and six-months
Change from baseline to six-months in assessments of functional fitness of sedentary adults with MS
Periodo de tiempo: Baseline and six-months

Measurements will include:

Upper body strength -- bicep curls consisting of lifting a light hand-weight as many times as possible in 30-seconds;

Baseline and six-months
Change from baseline to six-months in assessments of functional fitness of sedentary adults who have MS
Periodo de tiempo: Baseline and six-months

Measurements will include:

Balance -- a timed (up to 30-seconds) unassisted one-leg stand test with eyes open on each leg.

Baseline and six-months
Change from baseline to six-months in assessments of reported quality of life in people with MS
Periodo de tiempo: Baseline and six months
The Leeds Multiple Sclerosis Quality of Life Scale will be used as a disease specific quality of life measure for people with MS.
Baseline and six months
Change from baseline to six-months in assessments of reported quality of life in people with MS
Periodo de tiempo: Baseline and six-months
The Satisfaction with Life Scale will be used to assess global life satisfaction and is sensitive enough to detect changes in participants' perceptions over the course of a clinical intervention.
Baseline and six-months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change from baseline to six-months in assessments of cognitive performance in sedentary adults with MS
Periodo de tiempo: Baseline and six months
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery, which will be administered to assess cognitive performance.
Baseline and six months
Change from baseline to six-months in assessments of reported barriers self-efficacy in people with MS
Periodo de tiempo: Baseline and six months
Participants' situation-specific self-confidence for physical activity will be assessed using The Barriers Self-Efficacy Scale, which taps subjects' perceived capabilities to exercise three times per week for 40 minutes over the next two months in the face of commonly identified barriers to participation.
Baseline and six months
Changes in physical activity relating to specified exercise program in sedentary adults with MS
Periodo de tiempo: Baseline and six months
Adherence to exercise program as documented by daily exercise logs.
Baseline and six months
Objective changes in physical activity in sedentary adults with MS
Periodo de tiempo: Baseline and six months
Objective assessment of physical activity via accelerometry over seven days time.
Baseline and six months
Self-reported changes in physical activity in sedentary adults with MS
Periodo de tiempo: Baseline and six months
Subjective assessment of physical activity via the Godin Leisure Time Exercise Questionnaire, which assesses frequency of involvement in strenuous, moderate and light activities.
Baseline and six months
Change from baseline to six-months in assessments of reported gait self-efficacy in sedentary adults with MS
Periodo de tiempo: Baseline and six-months
Participants' situation-specific self-confidence for physical activity will be assessed using The Gait Self-Efficacy Scale, which will assess participants' beliefs in their capabilities to negotiate stairs and objects in their path.
Baseline and six-months
Change from baseline to six-months in assessments of reported exercise self-efficacy in sedentary people with MS
Periodo de tiempo: Baseline and six-months
The Exercise Self-Efficacy Scale will assess participants' beliefs in their ability to continue exercising on a three time per week basis at moderate intensities for 40+ minutes per session in the future.
Baseline and six-months
Change from baseline to six-months in assessments of reported self-efficacy of walking in sedentary people with MS
Periodo de tiempo: Baseline and six-months
Walking Self-Efficacy Scale for Duration will assess participants' beliefs in their physical capability to successfully complete incremental 5-minute intervals (up to 40 minutes)of walking at a moderately fast pace.
Baseline and six-months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Edward McAuley, PhD, University of Illinois at Urbana-Champaign

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de octubre de 2013

Finalización primaria (Actual)

1 de septiembre de 2014

Finalización del estudio (Actual)

1 de septiembre de 2014

Fechas de registro del estudio

Enviado por primera vez

18 de octubre de 2013

Primero enviado que cumplió con los criterios de control de calidad

20 de noviembre de 2013

Publicado por primera vez (Estimar)

25 de noviembre de 2013

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

23 de febrero de 2017

Última actualización enviada que cumplió con los criterios de control de calidad

21 de febrero de 2017

Última verificación

1 de febrero de 2017

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

3
Suscribir